| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.0065 | 0.8 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |